Detalhe da pesquisa
1.
Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?
Mult Scler Relat Disord
; 79: 105033, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832257